Profiling β Thalassemia Mutations in Consanguinity and Nonconsanguinity for Prenatal Screening and Awareness Programme

Table 3

Homozygosity versus compound heterozygosity in two groups.

	Consanguineous	Nonconsanguineous
Homozygous	6 (15%)	23 (6.3%)
Compound heterozygous	3 (7.5%)	62 (17.1%)